Testing the Addition of an Anti-cancer Drug, BAY 1895344, to the Usual Chemotherapy Treatment (Cisplatin, or Cisplatin and Gemcitabine) for Advanced Solid Tumors With Emphasis on Urothelial Cancer
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Jonsson Comprehensive Cancer Center
West China Hospital
German Cancer Research Center
The Affiliated Hospital of Qingdao University
Gene Surgery LLC
University Medical Center Groningen
Shanghai Bovax Biotechnology Co., Ltd.
HRYZ Biotech Co.
Deciphera Pharmaceuticals, LLC
Xencor, Inc.
Abramson Cancer Center at Penn Medicine
Oryx GmbH & Co. KG
Alliance for Clinical Trials in Oncology
Regeneron Pharmaceuticals
Regeneron Pharmaceuticals
National Cancer Institute (NCI)
National Institutes of Health Clinical Center (CC)